arrow
R

Rebecca L. Ross

University of Leeds
H指数:19
被引数:1,433

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Targeting Tenascin-C-Toll-like Receptor 4 signalling with Adhiron-derived small molecules - a viable strategy for reducing fibrosis in systemic sclerosis” [Bioorg. Chem. 167 (2025) 109251]

勘误:“Targeting Tenascin-C-Toll-like Receptor 4 signalling with Adhiron-derived small molecules - a viable strategy for reducing fibrosis in systemic sclerosis” [Bioorg. Chem. 167 (2025) 109251]

2025-12-110
OAAI
Targeting tenascin-C-toll-like receptor 4 signalling with Adhiron-derived small molecules - a viable strategy for reducing fibrosis in systemic sclerosis

靶向tenascin-C-toll-like receptor 4信号通路,使用Adhiron衍生的small molecules——一种减轻系统性硬化症纤维化的可行策略

2025-11-150
PRE
Transforming growth factor beta (TGF-β) induces type 1 interferon signalling in systemic sclerosis keratinocytes through the chloride intracellular channel 4 (CLIC4)

转化生长因子β(TGF-β)通过氯离子通道4(CLIC4)诱导系统性硬化症角化细胞中Ⅰ型干扰素信号通路。

2025-10-030
OAAI
Morphological reprogramming of primary cilia length mitigates the fibrotic phenotype in fibroblasts across diverse fibrotic conditions

原代纤毛长度形态的重编程可减轻多种纤维化条件下的成纤维细胞纤维化表型

2025-10-010
PRE
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study

血清I型干扰素评分作为弥漫性皮肤系统性硬化症患者疾病活动性生物标志物:一项回顾性队列研究

2025-03-310
PRE
Molecular glues that inhibit deubiquitylase activity and inflammatory signaling

能够抑制去泛素化酶活性和炎症信号通路的分子胶。

2025-03-170
OA
Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

系统性硬化症的生物学特征存在于系统性硬化症极早期诊断(VEDOSS)患者的皮肤和血清中。

2024-12-191
PRE
Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease

成人斯蒂尔病患者的遗传景观和新型炎症生物标志物的表征

2024-12-160
OAAI
The f3-Secretase BACE1 Drives Fibroblast Activation in Systemic Sclerosis through the APP/(3-Catenin/Notch (3-Catenin/Notch Signaling Axis
2024-10-010
OAAI